Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Jul 31, 2025

SELL
$49.77 - $79.97 $704,593 - $1.13 Million
-14,157 Closed
0 $0
Q4 2024

Jul 31, 2025

SELL
$40.61 - $58.21 $56,975 - $81,668
-1,403 Reduced 9.02%
14,157 $722,000
Q3 2024

Jul 31, 2025

SELL
$40.68 - $58.62 $13,302 - $19,168
-327 Reduced 2.06%
15,560 $641,000
Q2 2024

Jul 31, 2025

SELL
$37.11 - $50.69 $23,045 - $31,478
-621 Reduced 3.76%
15,887 $764,000
Q1 2024

Jul 31, 2025

BUY
$40.65 - $65.76 $104,226 - $168,608
2,564 Added 18.39%
16,508 $792,000
Q4 2023

Jul 31, 2025

SELL
$48.3 - $68.06 $167,504 - $236,032
-3,468 Reduced 19.92%
13,944 $905,000
Q3 2023

Jul 31, 2025

BUY
$54.2 - $71.67 $326,284 - $431,453
6,020 Added 52.84%
17,412 $1.14 Million
Q2 2023

Jul 31, 2025

SELL
$56.23 - $71.17 $33,850 - $42,844
-602 Reduced 5.02%
11,392 $662,000
Q1 2023

Jul 31, 2025

SELL
$53.43 - $68.12 $5,236 - $6,675
-98 Reduced 0.81%
11,994 $740,000
Q4 2022

Feb 06, 2023

BUY
$61.23 - $83.62 $7,102 - $9,699
116 Added 0.97%
12,092 $768,000
Q3 2022

Nov 01, 2022

BUY
$65.58 - $84.69 $94,763 - $122,377
1,445 Added 13.72%
11,976 $870,000
Q2 2022

Jul 18, 2022

SELL
$52.13 - $93.81 $95,345 - $171,578
-1,829 Reduced 14.8%
10,531 $716,000
Q1 2022

May 16, 2022

SELL
$64.92 - $99.47 $42,198 - $64,655
-650 Reduced 5.0%
12,360 $1.12 Million
Q4 2021

Feb 08, 2022

SELL
$76.51 - $93.96 $42,539 - $52,241
-556 Reduced 4.1%
13,010 $1.19 Million
Q2 2021

Aug 03, 2021

BUY
$79.62 - $114.85 $80,097 - $115,539
1,006 Added 8.01%
13,566 $1.27 Million
Q1 2021

May 12, 2021

SELL
$77.91 - $125.92 $939,906 - $1.52 Million
-12,064 Reduced 48.99%
12,560 $1.34 Million
Q4 2020

Feb 16, 2021

BUY
$60.0 - $87.29 $1.48 Million - $2.15 Million
24,624 New
24,624 $2.15 Million

Others Institutions Holding NARI

About Inari Medical, Inc.


  • Ticker NARI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,389,700
  • Market Cap $4.27B
  • Description
  • Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...
More about NARI
Track This Portfolio

Track Brinker Capital Investments, LLC Portfolio

Follow Brinker Capital Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brinker Capital Investments, LLC with notifications on news.